Foley Trasimene Acquisition Corp. (WPF.U), announced the pricing of their upsized $900 million SPAC IPO this evening and the units are expected to begin trading tomorrow, Wednesday, May 27th, under the symbol NYSE: WPF.U.
Foley Trasimene Acquisition Corp. will be sponsored by Bilcar FT, LP, an affiliate of Bilcar Limited Partnership, and Trasimene Capital FT, LP, an affiliate of Trasimene Capital Management, LLC, both led by William P. Foley, who will be this SPAC’s Executive Chairman. Mr. Foley will be joined by Richard Massey, as CEO.
Total SPAC deal count for 2020 year-to-date is now 28 with $9.161 billion in gross proceeds raised. The offering is anticipated to close on Friday, May 29, 2020.
Credit Suisse Suisse Securities (USA) LLC and BofA Securities are acting as joint book-running managers for this offering. Weil, Gotshal & Manges LLP and Davis Polk & Wardwell LLP were Issuer’s Counsel and Underwriter’s Counsel, respectively. WithumSmith+Brown, PC acted as auditor.
Jena II (NYSE:JENAU) has filed for a $200 million SPAC that brings serial SPAC leader William P. Foley II and his team back into the ring. This pedigree is clear in the terms the team has been able to command with just one right to a 1/20 share in each unit and 24 months to...
At the SPAC of Dawn Investors are set to get an update on Core CPI inflation readings this morning as de-SPACs continue to report on operational advances alongside their first quarter earnings. Among them, eVTOL developer Archer (NYSE:ACHR) noted that it is on track to deliver its first Midnight aircraft to the UAE in the...
Perimeter Acquisition Corp. I (NASDAQ:PMTRU) announced the pricing of its upsized $210 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “PMTRU”, Tuesday, May 13, 2025. The new SPAC aims to combine with a target company with that can contribute to the re-industrialization of the United States economy,...
Horizon Space II (NASDAQ:HSPT) has signed a definitive agreement to combine with clinical stage biotech firm SL Bio Ltd. for $5.57 billion in equity consideration. Taipei, Taiwan-based SL Bio is developing drug candidates to treat several cancer types while also selling over-the-counter beauty products derived from natural extracts. The combined company is expected to trade...
At the SPAC of Dawn This is set to be a slower week for votes with just two SPACs seeking an extension and none yet scheduling a meeting for approving a business combination. Integrated Rail & Resources (OTC:IRRX) primed the pump somewhat for investors ahead of its Tuesday special meeting by announcing it has entered...